Use of botulinum toxin for treating cardiovasular diseases

Details for Australian Patent Application No. 2003220511 (hide)

International Classifications

Event Publications

31 July 2003 Complete Application Filed

Priority application(s): 10/114,740 01.04.02 US

27 November 2003 Application Open to Public Inspection

Published as AU-B-2003220511

16 November 2006 Application Accepted

Published as AU-B-2003220511

4 January 2007 Amendment Made

The nature of the amendment is: Amend the title to read Use of botulinum toxin for treating cardiovascular diseases

8 March 2007 Opposition Lodged

Solstice Neurosciences, Inc. has lodged an opposition against Allergan, Inc.

31 May 2007 Opposition Withdrawn

The opposition by Solstice Neurosciences, Inc. against Allergan, Inc has been withdrawn.

11 October 2007 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 23 Aug 2007. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000

6 March 2008 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 23 Aug 2007

17 July 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.